Connect with us

Men's Sex

Testosterone Auto-Injector Deemed Safe | SexHealthMatters.org

Published

on

Testosterone Auto-Injector Deemed SafeAn auto-injector used to administer testosterone enanthate “has a favorable safety profile and is well-tolerated,” according to a new journal of Sexual Medicine study.

The device offers a convenient option for men on testosterone replacement therapy, allowing them to self-administer their medicine at home.

Testosterone is a male sex hormone that gives men their masculine traits. It’s also important for sex drive and erections. When men have a testosterone deficiency, they may feel moody, fatigued, and less interested in sex. For some men, testosterone replacement therapy relieves those symptoms.

Self-injectable testosterone was approved by the U.S. Food and Drug Administration in October 2018 for men whose bodies cannot produce adequate amounts of testosterone on their own. It has not been approved for men whose testosterone levels decline as a normal part of aging.

The study involved 133 men between the ages of 18 and 75 who had testosterone deficiency with symptoms. (Low testosterone, in this case, was diagnosed at levels below 300 ng/dL.)

1
2
Next »
(page 1 of 2)

Source link

Men's Sex

Birth Control Pills for Men are Possible, Studies Suggest

Published

on

By

Birth Control Pills for Men are Possible, Studies SuggestBirth control pills may eventually be available for men, scientists say.

A final product may still be years in the making, but researchers have deemed the medications safe and tolerable for healthy men.

The results of one study were presented at the annual meeting of the Endocrine Society in March 2019.

The drug, 11-beta-MNTDC, may reduce the production of sperm without decreasing a man’s libido. The drug behaves like testosterone, the hormone that drives sexual desire and gives men some of their masculine characteristics. But it does not trigger sperm production in the testes.

Forty healthy men participated in the 28-day study. Each day, 14 men took 200 mg of the 11-beta-MNTDC drug, and 16 men took 400 mg. The remaining 10 men took a placebo pill.

1
2
Next »
(page 1 of 2)

Source link

Continue Reading

Men's Sex

Peyronie’s Disease: More Men Receiving CCH Injections

Published

on

By

Peyronie’s Disease: More Men Receiving CCH Injections Nowadays, more men with Peyronie’s disease are being treated with injections of collagenase clostridium histolyticum (CCH) than surgery, according to recent research.

Peyronie’s disease is characterized by plaques of hardened scar tissue that form on the penis, just below the skin’s surface. The plaques make the penis lose some of its flexibility. As a result, the penis starts to bend. Sometimes, the curve is so severe that intercourse is difficult. Men with Peyronie’s disease may also experience pain and erectile dysfunction (ED).

Surgery to correct the curve is a common treatment. CCH injections, which are targeted directly at the plaques, were approved in 2014.

The study findings are based on insurance claims data for 36,156 men who were first diagnosed with Peyronie’s disease between 2011 and 2017. Diagnosis rates did not change much during that period.

In 2014, the treatment rate with either CCH or surgery was 9.8%, but the rate rose to 15.5% by 2017, reflecting an increase in men undergoing CCH injections. After CCH injections were approved, their use as a first-line treatment increased an average of 1.6% per year.

The ratio of CCH to surgery as a first-line treatment increased from 1:1 in 2014 to about 2:1 by 2017.

1
2
Next »
(page 1 of 2)

Source link

Continue Reading

Men's Sex

Low Testosterone Common in Germ Cell Tumor Survivors

Published

on

By

Low Testosterone Common in Germ Cell Tumor SurvivorsIn a recent study of germ cell tumor survivors, roughly half had hypogonadism – low testosterone – regardless of whether they were treated with surgery alone or surgery with platinum-based chemotherapy, scientists report in the journal Supportive Care in Cancer.

However, patients who had chemotherapy added to their surgical treatment were more likely to have male aging symptoms.

Germ cells are reproductive cells: egg cells in females and sperm cells in males. Tumors form when these cells grow and accumulate in an abnormal way. Some germ cell tumors are cancerous. When they are, they usually develop into ovarian cancer or testicular cancer.

The study included 199 germ cell tumor survivors between the ages of 18 and 50. Each participant completed a quality of life questionnaire at the start of the study and again three and six months later.

About 48% of the entire group had low testosterone. (For this study, hypogonadism was diagnosed if a man’s testosterone levels were below 300 ng/dL.)

Next, the researchers looked at testosterone levels based on type of treatment. Among patients who had had both surgery and chemotherapy, the low testosterone rate was 51%. For those who had surgery alone, the rate was 45%.

Patients who had low testosterone levels were more likely to have reported fatigue, poor sleep quality, and worse general health at the start of the study.

When the scientists compared quality of life assessment scores for the two groups, they found no statistically significant differences. However, those who had had both surgery and chemotherapy “exhibited more symptoms related to male aging.”

Resources

Mayo Clinic

“Germ cell tumors”

(May 25, 2019)

https://www.mayoclinic.org/diseases-conditions/germ-cell-tumors/symptoms-causes/syc-20352493

Oncology Learning Network

Porcelli, Hina

“Surgery With or Without Chemo Yields Low Testosterone in GCT Survivors”

https://www.oncnet.com/news/surgery-or-without-chemo-yields-low-testosterone-gct-survivors

Ovarian Cancer Research Alliance

“Chemotherapy”

https://ocrahope.org/patients/about-ovarian-cancer/treatment/chemotherapy/

Supportive Care in Cancer

Khanal, N., et al.

“The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy”

(Abstract. Published: November 9, 2019)

https://link.springer.com/article/10.1007/s00520-019-05117-0

WebMD

“What Are Germ Cell Tumors?”

(Reviewed: October 12, 2019)

https://www.webmd.com/cancer/germ-cell-tumors#1

Source link

Continue Reading

Trending